COVID-19 surveillance continues after U.S. Public Health Emergency declaration expires

This surveillance report outlines the status of COVID-19 monitoring in the United States after the expiration of the U.S. Public Health Emergency (PHE) declaration. The report does not specify a study phase, sample size, or follow-up period. The exposure of interest is the policy change itself, with no comparator group defined. No primary or secondary outcomes, main results, effect sizes, or statistical measures are reported in the provided data. The report does not include information on safety, adverse events, or tolerability related to the surveillance systems. Key limitations are not explicitly listed, and funding sources or conflicts of interest are not reported. The practice relevance of the report is also not specified. Given the descriptive nature of this surveillance update and the absence of comparative data or outcome measures, its direct clinical utility for patient management is limited. It serves primarily as an administrative notice regarding the continuity of public health monitoring.